Rapid induction of REDD1 gene expression in macrophages in response to stress-related catecholamines

Immunology Letters

Volumn 158, Issue 1-2, 2014, Pages 109-115

  Yanagawa, Yoshiki ^a   Hiraide, Sachiko ^a   Matsumoto, Machiko ^a   Togashi, Hiroko ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

2 Adrenoceptor; Catecholamines; Macrophages; REDD1

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HEAT SHOCK PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; NORADRENALIN; REGULATED IN DEVELOPMENT AND DNA DAMAGE RESPONSES 1; SALMETEROL; UNCLASSIFIED DRUG; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DDIT4 PROTEIN, MOUSE; EPAC PROTEIN, MOUSE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROPANOLAMINE DERIVATIVE; SALBUTAMOL; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRESS; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALBUTEROL; ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EPINEPHRINE; FEMALE; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84891898331     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.12.015     Document Type: Article

References (34)

1. Chrousos G.P. Stress and disorders of the stress system. Nat Rev Endocrinol 2005, 5:374-381.
2. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 2005, 5:243-251.
3. Franco R., Pacheco R., Lluis C., Ahern G.P., O'Connell P.J. The emergence of neurotransmitters as immune modulators. Trends Immunol 2007, 28:400-407.
4. Goyarts E., Matsui M., Mammone T., Bender A.M., Wagner J.A., Maes D., et al. Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp Dermatol 2008, 17:188-196.
5. Zinyama R.B., Bancroft G.J., Sigola L.B. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-α and interleukin-10. Immunology 2010, 104:439-446.
6. 2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. J Immunol 2010, 185:5762-5768.
7. Yanagawa Y., Matsumoto M., Togashi H. Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells. Brain Behav Immun 2011, 25:1427-1433.
8. Polumuri S.K., Jayakar G.G., Shirey K.A., Roberts Z.J., Perkins D.J., Pitha P.M., et al. Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J Immunol 2012, 189:50-60.
9. Ohno T., Morita H., Arae K., Matsumoto K., Nakae S. Interleukin-33 in allergy. Allergy 2012, 67:1203-1214.
10. Kageyama Y., Torikai E., Tsujimura K., Kobayashi M. Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33. Mod Rheumatol 2012, 22:89-93.
11. Brugarolas J., Lei K., Hurley R.L., Manning B.D., Reiling J.H., Hafen E., et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004, 18:2893-2904.
12. Wang Z., Malone M.H., Thomenius M.J., Zhong F., Xu F., Distelhorst C.W. Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic signals. J Biol Chem 2003, 278:27053-27058.
13. Ellisen L.W., Ramsayer K.D., Johannessen C.M., Yang A., Beppu H., Minda K., et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002, 10:995-1005.
14. Sofer A., Lei K., Johannessen C.M., Ellisen L.W. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 2005, 25:5834-5845.
15. Sengupta S., Peterson T.R., Sabatini D.M. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 2010, 40:310-322.
16. Mata M.A., Satterly N., Versteeg G.A., Frantz D., Wei S., Williams N., et al. Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor. Nat Chem Biol 2011, 7:712-719.
17. Clarke S., Greaves D.R., Chung L.P., Tree P., Gordon S. The human lysozyme promoter directs reporter gene expression to activated myelomonocytic cells in transgenic mice. Proc Natl Acad Sci USA 1996, 93:1434-1438.
18. Yuan J.S., Reed A., Chen F., Stewart C.N. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006, 7:85.
19. 1-adrenoceptor. Cell Mol Life Sci 2010, 67:405-417.
20. 2-Adrenoceptor subtypes-mediated physiological, pharmacological actions. Neurochem Int 2009, 55:447-453.
21. Davis E., Loiacono R., Summers R.J. The rush to adrenaline: drugs in sport acting on the β-adrenergic system. Br J Pharmacol 2008, 154:584-597.
22. 2-selective agonists. Br J Pharmacol 1997, 121:1059-1064.
23. + channels and stimulate cortisol secretion by a protein kinase A-independent mechanism. Mol Pharmacol 2009, 76:1290-1301.
24. 1 induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor. FASEB J 2012, 26:3199-3211.
25. Maestroni G.J. Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development. J Neuroimmunol 2002, 129:106-114.
26. Curtin N.M., Mills K.H., Connor T.J. Psychological stress increases expression of IL-10 and its homolog IL-19 via β-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide. Brain Behav Immun 2009, 23:371-379.
27. Koga K., Takaesu G., Yoshida R., Nakaya M., Kobayashi T., Kinjyo I., et al. Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity 2009, 30:372-383.
28. Dhabhar F.S. Stress, leukocyte trafficking, and the augmentation of skin immune function. Ann NY Acad Sci 2003, 992:1-13.
29. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004, 130:1-37.
30. 3-adrenoceptors. Br J Pharmacol 2010, 160:1048-1061.
31. 2-adrenergic receptors. Cardiovasc Drugs Ther 1999, 13:123-126.
32. Grandoch M., Roscioni S.S., Schmidt M. The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. Br J Pharmacol 2010, 159:265-284.
33. Moon E.Y., Lee J.H., Lee J.W., Song J.H., Pyo S. ROS/Epac1-mediated Rap1/NF-κB activation is required for the expression of BAFF in Raw264.7 murine macrophages. Cell Signal 2011, 23:1479-1488.
34. + persons reverses the decrease in TLR-4-mediated TNF-α release through prolongation of MAPK pathway activation. J Immunol 2011, 187:6052-6058.